swot-logo

Intra-Cellular Therapies Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Intra-Cellular Therapies Inc has 27 Strengths, 5 Weaknesses, 1 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Strength Index (RSI) Bullish

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent Highest Return Stocks over Five Years - Nifty500

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

New 52 week high today

Relative Outperformance versus Industry over 10 Years

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Increasing Revenue every Quarter for the past 8 Quarters

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Company with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Annual Net Profits improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter